New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Survival of children with acute lymphatic leukemia has increased to 94%, study finds

Survival of children with acute lymphatic leukemia has increased to 94%, study finds

by Princess Máxima Center for Pediatric OncologyCredit: Unsplash/CC0 Public DomainThe five-year survival of all children with acute lymphatic leukemia (ALL) has continued to increase to 94%. This is e
Oncology January 23,2024
Survival of children with acute lymphatic leukemia has increased to 94%, study finds

Survival of children with acute lymphatic leukemia has increased to 94%, study finds

by Princess Máxima Center for Pediatric OncologyCredit: Unsplash/CC0 Public DomainThe five-year survival of all children with acute lymphatic leukemia (ALL) has continued to increase to 94%. This is e
Oncology January 23,2024
Study finds increased MDS/leukemia risks for survivors of common lymphoid neoplasms

Study finds increased MDS/leukemia risks for survivors of common lymphoid neoplasms

by Elana GotkineSurvivors of common lymphoid neoplasms (LNs) have increased risks for therapy-related myelodysplastic syndrome/acute myeloid leukemia (tMDS/AML), although risks have been lower in more
Oncology January 23,2024
Study finds increased MDS/leukemia risks for survivors of common lymphoid neoplasms

Study finds increased MDS/leukemia risks for survivors of common lymphoid neoplasms

by Elana GotkineSurvivors of common lymphoid neoplasms (LNs) have increased risks for therapy-related myelodysplastic syndrome/acute myeloid leukemia (tMDS/AML), although risks have been lower in more
Oncology January 23,2024
Study identifies enzyme that helps tumors evade the immune system

Study identifies enzyme that helps tumors evade the immune system

by Olivia Dimmer,Northwestern UniversityNorthwestern Medicine scientists in the Sonabend laboratory have identified an enzyme which aids tumors in evading the immune system. Credit: Northwestern
Oncology January 23,2024
Study identifies enzyme that helps tumors evade the immune system

Study identifies enzyme that helps tumors evade the immune system

by Olivia Dimmer,Northwestern UniversityNorthwestern Medicine scientists in the Sonabend laboratory have identified an enzyme which aids tumors in evading the immune system. Credit: Northwestern
Oncology January 23,2024
Study finds that brain tumors 'hack' the communication between neurons

Study finds that brain tumors 'hack' the communication between neurons

byThe Spanish National Cancer Research CentreThe metastasis (lighter green) is shown to interact with a neuron (brighter green). This neuron has been artificially marked for research, but is sur
Oncology January 23,2024
Study finds that brain tumors 'hack' the communication between neurons

Study finds that brain tumors 'hack' the communication between neurons

byThe Spanish National Cancer Research CentreThe metastasis (lighter green) is shown to interact with a neuron (brighter green). This neuron has been artificially marked for research, but is sur
Oncology January 23,2024
Each year spent working with certain chemicals raises risk of pancreatic cancer, finds study

Each year spent working with certain chemicals raises risk of pancreatic cancer, finds study

by Dennis ThompsonJobs that regularly expose you to certain chemicals appear to steadily increase your risk of pancreatic cancer, a new analysis reports.People with more than 20 years of exposure to s
Oncology January 23,2024
Each year spent working with certain chemicals raises risk of pancreatic cancer, finds study

Each year spent working with certain chemicals raises risk of pancreatic cancer, finds study

by Dennis ThompsonJobs that regularly expose you to certain chemicals appear to steadily increase your risk of pancreatic cancer, a new analysis reports.People with more than 20 years of exposure to s
Oncology January 23,2024
Study finds that trust in cancer information declined among Black Americans during the pandemic

Study finds that trust in cancer information declined among Black Americans during the pandemic

byTaylor & FrancisCredit: Unsplash/CC0 Public DomainTrust in information given out by the government on cancer fell sharply among the Black population—by almost half—during the COVID-19 pand
Oncology January 23,2024
Study finds that trust in cancer information declined among Black Americans during the pandemic

Study finds that trust in cancer information declined among Black Americans during the pandemic

byTaylor & FrancisCredit: Unsplash/CC0 Public DomainTrust in information given out by the government on cancer fell sharply among the Black population—by almost half—during the COVID-19 pand
Oncology January 23,2024
Study finds large gap in breast cancer treatment recommendations for patients aged 70 vs. 69

Study finds large gap in breast cancer treatment recommendations for patients aged 70 vs. 69

byAmerican Society for Radiation OncologyCredit: Unsplash/CC0 Public DomainAge-based heuristics can lead to large differences in breast cancer treatment based on small differences in chronologic
Oncology January 23,2024
Study finds large gap in breast cancer treatment recommendations for patients aged 70 vs. 69

Study finds large gap in breast cancer treatment recommendations for patients aged 70 vs. 69

byAmerican Society for Radiation OncologyCredit: Unsplash/CC0 Public DomainAge-based heuristics can lead to large differences in breast cancer treatment based on small differences in chronologic
Oncology January 23,2024
Insurance status mediates racial, ethnic inequities in cervical cancer, finds study

Insurance status mediates racial, ethnic inequities in cervical cancer, finds study

by Elana GotkineInsurance status mediates racial and ethnic inequities in advanced-stage cervical cancer diagnosis, according to a study published online March 10 inJAMA Network Open.Hunter K. H
Oncology January 23,2024
Insurance status mediates racial, ethnic inequities in cervical cancer, finds study

Insurance status mediates racial, ethnic inequities in cervical cancer, finds study

by Elana GotkineInsurance status mediates racial and ethnic inequities in advanced-stage cervical cancer diagnosis, according to a study published online March 10 inJAMA Network Open.Hunter K. H
Oncology January 23,2024
Study finds 5-year relative survival rate of 59.6 percent in lower-risk myelodysplastic syndromes

Study finds 5-year relative survival rate of 59.6 percent in lower-risk myelodysplastic syndromes

by Elana Gotkine HealthDay ReporterAbout 40 percent of patients with lower-risk myelodysplastic syndromes (LR-MDS) die of MDS within five years, according to a study published online Nov. 6 in the&nbs
Oncology January 23,2024
Study finds 5-year relative survival rate of 59.6 percent in lower-risk myelodysplastic syndromes

Study finds 5-year relative survival rate of 59.6 percent in lower-risk myelodysplastic syndromes

by Elana Gotkine HealthDay ReporterAbout 40 percent of patients with lower-risk myelodysplastic syndromes (LR-MDS) die of MDS within five years, according to a study published online Nov. 6 in the&nbs
Oncology January 23,2024
Renowned tumor suppressor has prominent role in tissue repair, study finds

Renowned tumor suppressor has prominent role in tissue repair, study finds

by Krista Conger,Stanford UniversityCredit: AI-generated imageA protein famed among scientists and clinicians for its ability to suppress the development of many types of tumors may just be moon
Oncology January 23,2024
Renowned tumor suppressor has prominent role in tissue repair, study finds

Renowned tumor suppressor has prominent role in tissue repair, study finds

by Krista Conger,Stanford UniversityCredit: AI-generated imageA protein famed among scientists and clinicians for its ability to suppress the development of many types of tumors may just be moon
Oncology January 23,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com